CorMedix Inc
NASDAQ:CRMD

Watchlist Manager
CorMedix Inc Logo
CorMedix Inc
NASDAQ:CRMD
Watchlist
Price: 11.47 USD -1.29% Market Closed
Market Cap: 903.7m USD

Wall Street
Price Targets

CRMD Price Targets Summary
CorMedix Inc

Wall Street analysts forecast CRMD stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CRMD is 19.38 USD with a low forecast of 14.14 USD and a high forecast of 23.1 USD.

Lowest
Price Target
14.14 USD
23% Upside
Average
Price Target
19.38 USD
69% Upside
Highest
Price Target
23.1 USD
101% Upside
CorMedix Inc Competitors:
Price Targets
TBPH
Theravance Biopharma Inc
55% Upside
ETON
Eton Pharmaceuticals Inc
86% Upside
512
Grand Pharmaceutical Group Ltd
49% Upside
200670
Humedix Co Ltd
67% Upside
688321
Shenzhen Chipscreen Biosciences Co Ltd
37% Upside
4516
Nippon Shinyaku Co Ltd
28% Downside
ARVN
Arvinas Inc
1% Upside

Revenue
Forecast

Revenue Estimate
CorMedix Inc

The compound annual growth rate of CorMedix Inc's revenue for the next 3 years is 114%.

N/A
Past Growth
114%
Estimated Growth
Estimates Accuracy
10%
Average Beat

Operating Income
Forecast

Operating Income Estimate
CorMedix Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-9%
Average Miss

Net Income
Forecast

Net Income Estimate
CorMedix Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-66%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CRMD's stock price target?
Price Target
19.38 USD

According to Wall Street analysts, the average 1-year price target for CRMD is 19.38 USD with a low forecast of 14.14 USD and a high forecast of 23.1 USD.

What is CorMedix Inc's Revenue forecast?
Projected CAGR
114%

The compound annual growth rate of CorMedix Inc's revenue for the next 3 years is 114%.

Back to Top